Please login to the form below

Not currently logged in
Email:
Password:

Prism Ideas appoints Nigel Brooksby

Medical communications and drug development consultancy, Prism Ideas, has appointed Nigel Brooksby as non-executive chairman

Prism Ideas, a provider of medical communications and drug development consultancy services, has announced the appointment of Nigel Brooksby as non-executive chairman.

Brooksby has more than 35 years' experience in the life sciences industry, culminating in his position as chairman and managing director for sanofi-aventis UK and also successfully leading the UK's Association of the British Pharmaceutical Industry (ABPI) for two years.

Earlier this year Brooksby was made chairman of the board of trustees of the Primary Care Cardiovascular Society and was invited to join the advisory board of the Imperial Clinical Trials Unit at Imperial College London. In May, the Secretary of State for the Department for Business, Innovation and Skills (BIS) appointed him as a member of the Industrial Development Advisory Board.

"Prism Ideas is at a very exciting time in its development with a strong reputation for delivering scientific excellence and innovation," said Nigel Brooksby.

"I am delighted to be joining the company's leadership team and am looking forward to the opportunity to help build on its success."

1st September 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics